A new revenue model that defines how a company creates and capitalizes economic value, typically impacting its value proposition, product offering, operational strategies, and brand positioning

Defense forces have always pursued digitalization; however, its adoption has lagged behind commercial industries in recent times. Historically, computers have been used to manage logistics, supply inventory, pay wages, and maintain personnel records. There is also a rapid increase in digital adoption on the battlefield with advances in automated processing and sensor technologies

The agriculture industry is one of the biggest and most revenue-generating industries in the world. The agricultural production by the farmers helps in tackling the global food demand, which is expected to increase with the growing population. Farmers worldwide depend on agricultural production for their livelihood, and increased efficiency in the field would help in the upliftment of farmers and an increased global agricultural production. Farm management software and data analytic solutions can play a significant role in the growth of the global agricultural sector.

Epigenetics modification, including histone modification, DNA methylation, and RNA-mediated processes modification, are key to impact gene expression primarily at the level of transcription; disturbing any of three marks that contribute to epigenetic modification can cause abnormal activation or silencing of genes. However, other steps in the process (for example, translation) may also be regulated epigenetically. The current study aims to assess the global epigenetics market by focusing on products (consumables, instruments, software) catering to end users, including pharmaceutical and biotechnology companies, academic and research institutions, contract research organizations (CROs), and other end users. The current market for epigenetics is majorly dominated by manufacturers and service providers such as Thermo Fisher Scientific Inc, Illumina, Inc, Bio-Rad Laboratories, Inc, PerkinElmer Inc, Agilent Technologies, Inc, F. Hoffmann-La Roche Ltd., Exact Sciences Corporation, Merck Group, Abcam plc., MDxHealth, Pacific Biosciences of California, Inc, QIAGEN N.V., Zymo Research Corporation, Active Motif, and Promega Corporation among others.

The study defines that to accelerate the speed of chemical reactions, biological catalysts are required, particularly when there is a need to catalyze reactions that occur within the body of a living being. Ligases are those biological catalysts that seal the ends of enormous molecules like DNA. These enzymes are broadly utilized in molecular cloning, gene synthesis, next-generation sequencing, and many consequent by-products of DNA biotechnology. These enzymes particularly are also used for rectifying dysfunctions and the absence of DNA ligases in humans, which has a huge potential to revolutionize molecular diagnostics and malignant growth detection.

The research provides an overview of all the M&As and divestitures in the medtech industry during the study period. The M&As focus on three primary areas: The clinical specialty areas where the M&As occur. The purpose behind these deals. The impact of the consolidated landscape on healthcare providers, payers, patients, and other market players.

Medical grade tubing is a product designed for a number of applications that enable clinicians to perform several tasks, which normally include disposable applications such as medical catheters, IV sets, irrigation, drainage, and intravenous (IV) delivery. The applications are considered for medical applications such as abrasion protection, drug delivery, bulk disposable tubing, catheters, special applications, and other applications such as arthroscopy, endoscopy, and laparoscopy.

Diagnostics is an integral part of medical decision-making -- aid in acquiring information for a wide range of treatment dissemination, accentuating their criticality in healthcare. Molecular diagnostics has a critical role in precision medicine approach, as it ensures safe and effective application of targeted therapeutics. A majority of the players in the global molecular diagnostics market offer products encompassing the kits and reagents, instruments, and software categories. Also, several diagnostics and pharmaceutical companies are working collaboratively to develop NGS, PCR, IHC, ISH, microarray, nucleic acid amplification-, or mass spectrometry-based molecular diagnostics for the applications in several disease indications in order to enable efficient diagnosis, treatment selection, dosage selection, and treatment monitoring. Applications of molecular diagnostics primarily include infectious diseases, cancer, genetic testing, and women’s health, among others.

The global microbiome therapeutics market has witnessed significant growth, attributed to the increasing demand for therapeutic microbiomes imparting lesser side effects compared with the pre-existing standard of care. An underlying increase in the ongoing research and development activities pertaining to the clinical development of different microbiome therapeutics for a variety of indications is the key driver for the growth of the global microbiome therapeutics market.

Biomanufacturing is the process of production of commercially important biomolecules by utilizing biological systems for use in medicines, food and beverage processing, and industrial applications. Natural sources such as blood, cultures of microbes, animal cells, or plant cells are often employed to carry out biomanufacturing. Cells used in the production process can also be derived using genetic engineering techniques.